Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

<< Previous
Bullboard Posts
Next >>
Post by ISAloser247on Mar 09, 2021 9:38am
90 Views
Post# 32751329

GEE Dohts , PRESENTATION 'FACTS" AREN'T on NEWSWIRE ?

GEE Dohts , PRESENTATION 'FACTS" AREN'T on NEWSWIRE ?WHY?   most likely on ' CONSULTING '  with B D --the Internationally renowned experts recommended to keep it  ' inhouse '  for the 30 %  stakeholders .

UNICORN PIPE DREAMS OF CEAPRO ,   RARELY ,  PRACTICALLY  NEVER MATERIALIZE 

' OH , THAT FUNCTIONAL DRINK,  WITH THE YEAR END DEAL ,  OUI ,  just too  expensive to manufacture for a commercial product . (  WE DREAM BIG ,  cost annalysis, feasability studies,  THAT FOR  REAL  BUSINESS GUYS -----  WE HAVE A STABLE  BASE BUSINESS , TO  PARASITE SO I CAN PLAY BIO PHARMA EXECUTIVE ) )

...betaglucan pill study , first 'mentioned ' in 2016 ,  NOT FULLY ENROLLED in 2021 , ----results, findings, application for Approval ........COMMERCIAL PRODUCT ON MARKET if Feasible --2028?

...you know CEAPRO / GILLES has NO CREDIBILITY when pornoffacts  inserts a  LLAMAND Newwire article , in a pathetic post trying to tie in CEAPRO .
<< Previous
Bullboard Posts
Next >>